FOLR2 and myeloid sarcoma: Finally, and using [18F]FOL to target folate receptor-β (FR-β) that is expressed on activated macrophages, Elo et al. investigated the use of FR-β as a potential biomarker for neuroinflammation imaging in MS in comparison with [11C]PBR28 PET.